Moderna forecasts $18.4 billion revenue for 2021 PUBLISHED BY
$18.4 billion in 2021 from its Covid-19 vaccine deals.
Moderna, before it came up with the vaccine for the coronavirus, was going in losses. The company’s forecast of $18 billion-plus is quite higher than what Wall Street analysts have predicted for it. They put the revenue at $11.2 billion. Moderna reported revenue of $571 million in the fourth quarter, largely from the US government grants and sales of its Covid-19 vaccine.
Moderna is optimistic about its performance due to its discussions with governments about more vaccine orders for 2021 and 2022.
The company suffered a net loss of $272 million. It expects $350 million to $400million in capital expenditure in 2021. Total revenue was $803 million for the year ended December 31, 2020. Net loss was $747 million for the year, compared to $514 million for the year ended December 31, 2019.